Gemmer Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Gemmer Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-52	Closed	-$29K	–	223
2022 Q1	$29K	Buy	52 +2	+4%	+$1.21K	﹤0.01%	400
2021 Q4	$38K	Hold	50	–	–	﹤0.01%	335
2021 Q3	$37K	Hold	50	–	–	0.01%	307
2021 Q2	$32K	Hold	50	–	–	﹤0.01%	382
2021 Q1	$29K	Hold	50	–	–	﹤0.01%	382
2020 Q4	$29K	Hold	50	–	–	﹤0.01%	341
2020 Q3	$26K	Hold	50	–	–	﹤0.01%	323
2020 Q2	$23K	Hold	50	–	–	﹤0.01%	338
2020 Q1	$18K	Hold	50	–	–	﹤0.01%	350
2019 Q4	$19K	Hold	50	–	–	﹤0.01%	406
2019 Q3	$17K	Hold	50	–	–	﹤0.01%	439
2019 Q2	$16K	Hold	50	–	–	﹤0.01%	447
2019 Q1	$15K	Hold	50	–	–	﹤0.01%	506
2018 Q4	$12K	Hold	50	–	–	﹤0.01%	527
2018 Q3	$16K	Hold	50	–	–	0.01%	476
2018 Q2	$14K	Hold	50	–	–	﹤0.01%	540
2018 Q1	$13K	Hold	50	–	–	﹤0.01%	558
2017 Q4	$12K	Hold	50	–	–	﹤0.01%	618
2017 Q3	$11K	Hold	50	–	–	﹤0.01%	612
2017 Q2	$11K	Hold	50	–	–	﹤0.01%	594
2017 Q1	$10K	Hold	50	–	–	﹤0.01%	632
2016 Q4	$9K	Hold	50	–	–	﹤0.01%	643
2016 Q3	$8K	Hold	50	–	–	﹤0.01%	682
2016 Q2	$7K	Hold	50	–	–	﹤0.01%	701
2016 Q1	$6K	Hold	50	–	–	﹤0.01%	738
2015 Q4	$7K	Hold	50	–	–	﹤0.01%	671
2015 Q3	$7K	Hold	50	–	–	﹤0.01%	657
2015 Q2	$8K	Hold	50	–	–	﹤0.01%	639
2015 Q1	$7K	Hold	50	–	–	﹤0.01%	752
2014 Q4	$6K	Hold	50	–	–	﹤0.01%	772
2014 Q3	$6K	Hold	50	–	–	﹤0.01%	767
2014 Q2	$6K	Hold	50	–	–	﹤0.01%	819
2014 Q1	$6K	Buy	+50	New	+$6.41K	﹤0.01%	791

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gemmer Asset Management's BIO Position: Q2 2022 in Review

Gemmer Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2022, closing a stake of 52 shares — an estimated $29K sold.

Gemmer Asset Management first reported a position in BIO in Q1 2014 and held it in 33 quarters. The position peaked at $38K in Q4 2021. 500 funds tracked by Wall St. Rank hold BIO as of Q2 2022.

Gemmer Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 52 Bio-Rad Laboratories Class A shares in Q2 2022, an estimated $29K.
Gemmer Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2014 and held it in 33 quarters.
Gemmer Asset Management's Bio-Rad Laboratories Class A position peaked at $38K in Q4 2021.
500 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.